Enolase (2-phospho-D-glycerate hydrolase) enzyme has been characterized extensively and approved as a molecular drug target for rational drug discovery in apicomplexan such as Plasmodium spp., Toxoplasma gondii but not in the Theileria parva which causative agent of East Coast Fever engender serious economic losses. For the aim of identifying a key drug target, we have analyzed Theileria parva's enolase sequence and we have constructed three-dimensional structure of that enolase and mammalian host Bos taurus enolase (BtEno). Constructed model was approved, structurally analyzed and conceivable ligand binding pockets were identified for the first time in the literature. In this study, we reported significant findings, a pentapeptide and three different dipeptide insertions in TpEno (D103W104G105Y106C107, T147D148, K261E262, K317L318), when compare the sequences of enolase gene with its counterpart host BtEno. The homology modeling revealed that these insertions constituted loops that absent in B. taurus enolase seem to be important lead structures which can be used as binding sites for inhibition of TpEno.
Introduction
Apicomplexan parasites cause destructive human and animal diseases, which lead to the remarkable amount of economic losses throughout the world (Kumpula and Kursula, 2015) . The most widely known examples of those parasites are Plasmodium spp., Toxoplasma gondii, Theileria parva and Theileria annulata, which cause phylum-caused malaria, toxoplasmosis and east coast fever and tropical theileriosis, respectively. The East Coast Fever (ECF), which is also known as corridor disease, is an important tick-borne disease of cattle and it causes approximately $200 million of loss for farmers in Africa annually (Olwoch et al., 2008) .
The actual approaches for preventing these diseases caused by Theileria spp. reside on the utilization of acaricides for the tick control (Walker, 2007) , and chemotherapy (McHardy et al.,1985; Dolan et al., 1992) or immunization via the live attenuated cell-line vaccine for controlling the parasite in endemic areas (Bishop et al., 2001) . But, there are also some factors limiting the efficiency of struggle with disease such as high costs and resistance to acaricides (Walker, 2007) , requirement of liquid-nitrogen cold-chain for transferring the vaccine, possibility of vaccine-induced carrier stage, and also infection risk for unvaccinated cattle that graze together with vaccinated ones (Oura et al., 2004) . When used in early period, parvaquone and buparvaquone (Mchardy et al., 1985; Dolan et al., 1992) are the unique efficient chemotherapy options for parasitic development, because extensive destruction of hematopoietic and lymphoid tissues occurs in the later stage of the disease (Singh et al., 1993) . However, recently, it was reported that resistance had developed against the antitheilerial. The first report on buparvaquone resistance has been published in the year 2010 (Mhadhbi et al., 2010) and followed by a new case in the year 2012 caused by the point mutation mitochondrial cytochrome b gene in parasite (Sharifiyazdi et al.,2012; Mhadhbi et al., 2015) . As a result of these studies, it has been understood that there is a necessity for immediately developing a novel antitheilerial medication that acts through different modes of action. An important chemotherapeutic target is the glycolytic pathway of parasitic protozoa since it is the only way of meeting their energy requirements. After the genome sequencing of T. parva has been accomplished in year 2005 , it has been achieved important information about the metabolism of this parasite (Hayashida et al., 2013; Lau, 2009) . The result signified Theileria spp. have an unusual TCA cycle as only three of the four pyruvate dehydrogenase complex (PDH) subunits have been identified . Therefore, it has been suggested that T. parva, like Plasmodium spp., doesn't have any conventional TCA-cycle and dependence on glycolysis as a source of energy (Lau, 2009 ).
Enolase (2-phospho-D-glycerate hydrolase) is a necessary dimeric glycolytic enzyme, which acts as a catalyzer of interconversion of 2-phosphoglyceric acid (2-PGA) and phosphoenolpyruvate (PEP) during the glycolysis process (Labbe et al., 2006 ). That's why; the gene that is known to encode the T. parva enolase (TpEno) was chosen as the drug target since it is the main enzyme throughout the glycolytic process. In present study sequence analysis of TpEno and the homology modeling for the 3D structure of TpEno were performed for the first time in the literature. The aim of this process is to determine the key drug target through the comparative analyses of the 3D structure of the target and the mammalian host Bos taurus enolase (BtEno).
Materials and methods

Alignment of Amino Acid Sequence of TpEno with Some Known Enolase Sequences
Sequence of the amino acid belong to enolase of T. parva (TpEno), other apicomplexan parasites, host B. taurus and plants were retrieved from the National Centre for Biotechnology Information database (NCBI). The NCBI reference sequence used in this study were XP_764336.1, AAK38886.1, AAG60329.1, AAA18634.1, NP_001029874.1, AAM12985.1 for Theileria parva, Eimeria tenella, Toxoplasma gondii, Plasmodium falciparum, Bos taurus and Arabidopsis thaliana respectively. Lipper Centre for Computational Genetics, Harvard were used to comparing reverse and forward strand sequences. Sequences alignments at amino acid level were achieved by utilizing ClustalW2 (Chenna et al., 2003) . The positions of exons and introns were determined by the GSDS utility (Guo et al., 2007) .
Physiochemical, Functional Properties and Secondary Structure Prediction of TpEno
The physiochemical properties of TpEno, such as theoretical isoelectric point (pI), molecular weight, the total number of positive and negative residues, extinction coefficient, instability index, aliphatic index and grand average hydropathy (GRAVY), were performed by Expasy's ProtParam server (Gasteiger et al., 2003) . Secondary structure properties of the TpEno sequences was calculated by web-based program SOPMA (Geourjon and Deleage, 1995) .
Prediction and validation 3D structure of the TpEno and BtEno
An automatic 3D model of TpEno and BtEno were constructed based on structural homologies with a template protein using the program Protein Homology/analogy Recognition engine 2 (PHYRE2) a free online homology modeling server (Kelley et al., 2015) . This program utilizes the alignment of hidden Markov models through HHsearch to remarkably increase the efficiency of alignment and recognition rate. Energy minimization and root mean square deviation (RMSD) were performed using 3Drefine (Bhattacharya and Cheng, 2013) and SuperPose servers (Bhattacharya and Cheng, 2013) , respectively. To ensure the quality of modeling, stereochemistry, energy profile and residue environment of modeled structure were checked by different servers. RAMPAGE (Lovell et al., 2003) was used to test the stereochemistry of the model. The model was further examined by ProSA (Wiederstein and Sippl, 2007) and ERRAT servers (Colovos and Yeates, 1993) . Protein Structure Validation Suite-PSVS 1.3 (http://psvs-1_4-dev.nesg.org) was used to analyses the quality of the model.
Ligand Binding Site Identification
MetaPocket 2.0 server (Huang, 2009) was used to determine possible ligand-binding sites. The MetaPocket is an accord strategy enhanced at Technical University of Dresden and Zhejiang University together, in which the predicted binding sites from eight techniques, for example, PASS11 (PAS), LigsiteCS (LCS), Q_SiteFinder (QSF), GHECOM (GHE), POCASA (PCS), Fpocket (FPK), SURFNET (SFN), ConCavity (CON) are consolidated to build up the forecast achievement rate.
Result
Alignment of Amino Acid Sequence of TpEno with Some Known Enolase Sequences
The amino acid sequence of TpEno (XP_764336.1) was aligned with the amino acid sequences of some other species, Bos Taurus (NP_001029874.1), Plasmodium falciparum (AAA18634.1), Toxoplasma gondii (AAG60329.1), Eimeria tenella (AAK38886.1) and Arabidopsis thaliana (AAM12985.1) by ClustalW software. Alignment result revealed the presence of insertions or deletions at the same positions of TpEno compared of host organism Bos taurus (Fig. 1) . The most striking insertion consisted in the addition of a pentapeptide, three dipeptide insertions in TpEno, D103W104G105Y106C107, T147D148, K261E262, K317L318 respectively absent in BtEno (shown with a red frame at Fig. 1 ). This a pentapeptide and three dipeptide residue insertion may be a valuable unique target for antitheilerial design. Our alignment result also demonstrated that other apicomplexan parasites had similar insertion sites like TpEno (Fig. 1) . 
Physiochemical, Functional Properties and Secondary Structure Prediction of TpEno
Expasy's ProtParam server used to check stereochemistry, energy profiles, potential errors, nonbonding interactions and some physical and chemical properties of TpEno. Protein model is about 48056.01 kDa and calculated pI (isoelectric point) of the TpEno is 6.43. The total number of positively charged residues (Arg+Lys) is 53% and negatively charged residues (Asp+Glu) is 55%. The instability index of this enzyme was calculated as 27.68 which classifies the protein as stable. The aliphatic index (AI) which is defined as the relative volume of a protein occupied by aliphatic side chains (A, V, I and L), is regarded as a positive factor for the increase in thermal stability of globular proteins, and the calculated value was found to be 90.23. The grand average of hydropathicity (GRAVY) value is -0.186. The Secondary structure of TpEno was predicted by the self-optimized prediction method with the alignment (SOPMA) server. According to the result, alpha helix (45.70%) and random coil (27.83%) compose the large proportion of the physical feature. Extended strands and beta turns have found as 16.52% and 9.95% respectively.
Homology Modelling, Validation and Structural Differences between Enolase of T. parva and B. taurus
Based on the investigation in Plasmodium species, we investigated to determine a key drug target in view of homology modeling to design a highly specific drug based on the homology modeling three-dimensional (3D) structure of TpEno as a target with the final aim considering of data get from the sequence of TpEno. The amino acid sequence obtained from the NCBI (NCBI Reference Sequence: XP_764336.1) was used to model the 3D structure of TpEno (Figure 2. A) and B. taurus enolase (NCBI Reference Sequence: NP_001029874.1) (Figure 2 . B) by Phyre2 workspace for comparison with TpEno. Templates used for homology modeling of TpEno PDB ID was 3OTR and 2AKM was for BtEno. The Ramachandran plot for the predicted model by RAMPAGE reveals that 95.7% (421) residues were found in the most favorable region, 3.2% (14) residues in allowed regions and 1.1% (5) residues in outlier region (Fig. 3) . (421) residues were found in most favorable region, 3.2 % (14) residues in allowed regions and 1.1% (5) residues in outlier region.
For predict non-bonding interactions by examining the statistics of pairwise atomic interaction, ERRAT served was used. The obtained result showed that the model has a good resolution structure with 90.092 overall quality factor. ProSA server used for assessment overall quality of the modeled protein via the scores of all experimentally determined protein chains currently available in the Protein Data Bank (PDB. The program gave a-9.85 z-score and a plot of the residue energies for TpEno demonstrates modeled quality is acceptable and protein in model was within the range of the typically found proteins of similar size (Fig. 4) . 
Ligand Binding Site Identification
Protein-ligand binding site estimation from a 3D protein structure plays an essential role in rational drug design and can be helpful in drug side-effects prediction or clarification of protein function. In this study, we used MetaPocket 2.0 with considering top three sites to give the notice ligand binding side of TpEno which structure has not been solved yet (Table  1) . After grouping the main 3 sites from PAS, LCS, FPK, SFN, GHE, CON, there are 7 metaPocket clusters. The first MetaPocket site (MPK1) include 4 pocket sites; the first one from LigisiteCS (LCS-1), the first one from PASS (PAS-1), the first one from GHECOM (GHE-2), the first one from Concavity (CON-1) with total 11.42 z score. The second MetaPocket site (MPK2) contains 3 pocket sites; SFN-1(SURFNET), FPK-1(Fpocket) and CON-3 with the total 10.16 z score. The third MetaPocket site (MPK3) contains 4 pocket sites from PAS-2, SFN-2, LCS-3, GHE-1 and total 8.13 z score. The fourth MetaPocket site contains 2 pocket sites with 4.49 z score from LCS-2, CON-2. The fifth MetaPocket site contains 3 pocket sites from FPK-3, PAS-3, GHE-3 with total 2.06 z-score. The sixth MetaPocket site contains 1 pocket sites from SFN-3 and total zscore is 1.06. 
Conclusions
The determination of macromolecular targets that are necessary for the life of parasite is the first action for the drug design. Glycolytic enzymes are considered to have potential from this aspect. The energy supply of Plasmodium spp. are based on the glycolytic process (Foth et al., 2005) . As a result of extensive studies on Plasmodium spp. glycolytic enzymes, such as aldolase (Certa et al., 1988) , lactate dehydrogenase (Cameron et al., 2004; Piper et al., 1999) , enolase (PalBhowmick et al., 2004) , and triose phosphate isomerase (Maithal et al., 2002) were shown to have potential as detection tools, drug targets and vaccine candidates . Plasmodium spp. are the most species subjected to the structure based drug design among apicomplexan parasites. The crystal structure of Plasmodium falciparum LDH (PfLDH) reveals a significant property, a penta peptide insertion in the active site of the enzyme, leads to a separate cavity in the surface adjacent to the catalytic region that is mammalian equivalent LDH does not have the pentapeptide insertion (Dunn et al., 1996) . Based on these data, azole based inhibitors developed to bind active side of the of PfLDH protein to prevent the enzyme activity and the parasite advancement in red platelets (Cameron et al., 2004) . Among studies, it has been determined that the deletion of pentapeptide insertion (EWGWS) from the active region of P. falciparum enolase caused the decrease of kcat/Km values for 100 times (Pal-Bhowmick et al., 2004) . The mice vaccinated with P. falciparum enolase modified by deletion of this pentapeptide insertion region showed a trivial reaction when compared wild-type enolase. It has also been demonstrated that this insertion region is a necessity for the proper operation of enolase and it may generate a conservative antigenic epitope in parasite's enolase (Pal-Bhowmick et al., 2004) . From this aspect, specific inhibitors may be developed through cloning the parasitic enolase and comparatively analyzing with host mammalian enolase. In order to design a structure-based medication, we chose the Theileria parva enolase as our target. 3D structure was constructed and analyzed in combination with homology modeling and possible ligand binding sites have been identified in our study. As an important finding, a pentapeptide and three dipeptide insertions in TpEno (D103W104G105Y106C107, T147D148, K261E262, K317L318) were defined through comparing to the homology model of TpEno and its counterpart host BtEno. It was determined that the insertion regions, which are present on T.parva enolase, absent in host B. taurus enolase. Hence, these insertion sites can be used as the binding sites for specific enzyme inhibitors to be developed.
